Publications

5674 Results

Time to first progression is the best predictor of survival duration in SWOG standard dose chemotherapy studies

Authors
BGM Durie;J Jacobson;B Barlogie;JJ Crowley
Journal / Conference
Blood 100(11):210a(#790)
Year
2002
Research Committee(s)
Leukemia

Analysis of prognostic factors in Southwest Oncology Group stage III non-small cell lung cancer trials requiring pre-treatment histological assessment of mediastinal lymph nodes

Authors
CR Thomas Jr;K Chansky;KS Albain;MJ Kraut;VW Rusch;RB Livingston;JJ Crowley;DR Gandara
Journal / Conference
Int J Radiat Oncol Biol Phys 54(2):103-104(#174)
Year
2002
Research Committee(s)
Lung

Patterns of failure for resected advanced head & neck cancer treated by concurrent chemotherapy and radiation therapy: an analysis of RTOG 9501/Intergroup Phase III trial

Authors
JS Cooper;T Pajak;AA Forastiere;J Jacobs;SB Saxman;JA Kish;HE Kim;AJ Cmelak;M Rotman;M Machtay;JF Ensley;KC Chao;CJ Schultz;N Lee;KK Fu
Journal / Conference
Int J Radiat Oncol Biol Phys 54(2):2(#3)
Year
2002
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9515 (RTOG-9501)

In reply to the Letter to the Editor: Sentinel-node technique will change the design of clinical trials in malignant melanoma

Authors
JM Kirkwood;SS Agarwala;J Ibrahim;J Manola;VK Sondak;MS Ernstoff;MK Ross
Journal / Conference
Journal of Clinical Oncology 20(8):2209-2210
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9512 (E1694)

A simple classification to identify poor-risk untreated myeloma

Authors
PR Greipp;S Kumar;EA Blood;M Rue;J Jacobson;TM Therneu;DR Larson;KC Ancerson;MM Oken;RA Kyle
Journal / Conference
Blood 100(11):598a(#2351)
Year
2002
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321

Outcome for salvage total laryngetomy (TL) following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11

Authors
R Weber;B Berkey;A Forastiere;M Maor;H Goepfert;W Morrison;B Glisson;A Trotti;J Ridge;C Chao;G Peters;DJ Lee;A Leaf;J Ensley
Journal / Conference
American Head and Neck Society meeting (COSM):(#168)
Year
2002
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9201 (RTOG-91-11)

Larynx preservation and tumor control in stage III and IV laryngeal cancer: a three-arm randomized Intergroup trial; RTOG 91-11

Authors
MH Maor;B Berkey;A Forastiere;R Weber;H Goepfert;W Morrison;B Glisson;A Trotti;J Ridge;C Chao;G Peters;D Lee;A Leaf;J Ensley;KK Fu
Journal / Conference
Int J Radiat Oncol Biol Phys 54(2):2-3(#4)
Year
2002
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9201 (RTOG-91-11)

Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of Intergroup 0159, Cancer and Leukemia Group B 9480

Authors
EJ Small;S Halabi;MJ Ratain;G Rosner;W Stadler;D Palchak;E Marshall;R Rago;V Hars;G Wilding;D Petrylak;NJ Vogelzang
Journal / Conference
Journal of Clinical Oncology 20(16):3369-3375
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9452 (INT-0159) (CALGB 9480)

A phase I study of a HER-2/neu intracellular protein (HER2 ICD) vaccine in patients with HER2 overexpressing breast or ovarian cancer

Authors
K Schiffman;L Salazar;K Knutson;K Guthrie;M Disis
Journal / Conference
ASCO/Molecular Therapeutics Symposium, San Diego CA :#52
Year
2002

Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer

Authors
JC Weeks;H Nelson;S Gelber;D Sargent;G Schroeder
Journal / Conference
Journal of the American Medical Association 287(3):321-328
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9411